Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $868,048 | 371 | 74.8% |
| Travel and Lodging | $120,222 | 452 | 10.4% |
| Food and Beverage | $79,551 | 1,909 | 6.9% |
| Consulting Fee | $53,038 | 24 | 4.6% |
| Honoraria | $38,408 | 15 | 3.3% |
| Education | $1,309 | 23 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $292,865 | 450 | $0 (2024) |
| ABBVIE INC. | $190,758 | 481 | $0 (2024) |
| Celgene Corporation | $189,770 | 254 | $0 (2019) |
| PFIZER INC. | $99,931 | 202 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $91,709 | 137 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $90,046 | 207 | $0 (2024) |
| Incyte Corporation | $62,134 | 120 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $41,065 | 76 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $32,521 | 44 | $0 (2024) |
| Galderma Laboratories, L.P. | $29,550 | 52 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $179,788 | 359 | Amgen Inc. ($67,315) |
| 2023 | $184,883 | 336 | Amgen Inc. ($86,059) |
| 2022 | $152,674 | 436 | Amgen Inc. ($69,890) |
| 2021 | $90,355 | 332 | Amgen Inc. ($46,499) |
| 2020 | $58,968 | 224 | Amgen Inc. ($15,948) |
| 2019 | $141,000 | 372 | Celgene Corporation ($35,917) |
| 2018 | $201,970 | 413 | Celgene Corporation ($93,129) |
| 2017 | $150,938 | 322 | Celgene Corporation ($60,724) |
All Payment Transactions
2,794 individual payment records from CMS Open Payments — Page 1 of 112
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,971.00 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Travel and Lodging | In-kind items and services | $941.24 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $103.00 | General |
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $88.97 | General |
| Category: Immunology | ||||||
| 12/06/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,010.00 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $102.10 | General |
| Category: Immunology | ||||||
| 12/02/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $43.80 | General |
| Category: Immunology | ||||||
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $43.20 | General |
| Category: Immunology | ||||||
| 11/26/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $29.49 | General |
| Category: Immunology | ||||||
| 11/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $139.15 | General |
| 11/20/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: Immunology | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $114.51 | General |
| Category: Immunology | ||||||
| 11/19/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $102.85 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,400.00 | General |
| 11/12/2024 | Galderma Laboratories, L.P. | — | Travel and Lodging | Cash or cash equivalent | $331.36 | General |
| 11/12/2024 | Galderma Laboratories, L.P. | — | Travel and Lodging | Cash or cash equivalent | $321.60 | General |
| 11/12/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $102.85 | General |
| Category: Inflammation & Immunology | ||||||
| 11/12/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $46.45 | General |
| 11/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 2,302 | 6,117 | $640,459 | $184,562 |
| 2022 | 10 | 2,144 | 6,375 | $621,880 | $180,363 |
| 2021 | 19 | 2,319 | 6,684 | $667,882 | $217,233 |
| 2020 | 14 | 2,040 | 5,894 | $541,014 | $162,993 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 638 | 871 | $265,655 | $79,029 | 29.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 549 | 748 | $115,192 | $28,378 | 24.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 261 | 327 | $79,461 | $23,126 | 29.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 467 | 3,680 | $58,880 | $18,159 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 216 | 269 | $57,835 | $17,465 | 30.2% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 27 | 28 | $12,768 | $3,951 | 30.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 50 | 81 | $10,611 | $3,080 | 29.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 20 | 24 | $10,023 | $2,586 | 25.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $7,260 | $2,292 | 31.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 16 | 27 | $7,112 | $2,206 | 31.0% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 14 | 18 | $7,992 | $2,199 | 27.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 13 | 13 | $3,965 | $1,338 | 33.7% |
| 69100 | Biopsy of ear | Office | 2023 | 13 | 13 | $3,705 | $752.51 | 20.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 674 | 966 | $292,950 | $88,443 | 30.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 537 | 789 | $121,506 | $30,340 | 25.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 458 | 4,037 | $64,592 | $19,658 | 30.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 216 | 261 | $63,423 | $17,920 | 28.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 141 | 180 | $38,376 | $11,856 | 30.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 24 | 30 | $12,510 | $3,849 | 30.8% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2022 | 22 | 25 | $11,400 | $3,633 | 31.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 45 | 59 | $7,729 | $2,148 | 27.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $5,404 | $1,730 | 32.0% |
| 69100 | Biopsy of ear | Office | 2022 | 13 | 14 | $3,990 | $787.33 | 19.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 616 | 902 | $239,390 | $88,499 | 37.0% |
| 17000 | Destruction of skin growth | Office | 2021 | 504 | 802 | $123,508 | $31,348 | 25.4% |
About Dr. Robert Posnick, M.D
Dr. Robert Posnick, M.D is a Dermatology healthcare provider based in Nashua, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497866388.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Posnick, M.D has received a total of $1.2M in payments from pharmaceutical and medical device companies, with $179,788 received in 2024. These payments were reported across 2,794 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($868,048).
As a Medicare-enrolled provider, Posnick has provided services to 8,805 Medicare beneficiaries, totaling 25,070 services with total Medicare billing of $745,150. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Nashua, NH
- Active Since 08/31/2006
- Last Updated 09/20/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1497866388
Products in Payments
- Otezla (Drug) $465,413
- COSENTYX (Biological) $79,522
- EUCRISA (Drug) $75,975
- Humira (Biological) $70,776
- ILUMYA (Biological) $67,517
- OPZELURA (Drug) $59,623
- SKYRIZI (Biological) $44,818
- Sotyktu (Drug) $37,349
- RINVOQ (Biological) $29,522
- CIBINQO (Drug) $22,455
- Tremfya (Drug) $17,928
- TREMFYA (Drug) $16,724
- ILUMYA (tildrakizumab-asmn) injection (Biological) $15,373
- HUMIRA (Biological) $11,772
- COSENTYX (Drug) $10,434
- Skyrizi (Biological) $9,695
- DUPIXENT (Biological) $8,240
- Ilumya (Biological) $8,075
- Enbrel (Biological) $4,079
- Otezla (Biological) $3,402
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Nashua
David Posnick, Do, DO
Dermatology — Payments: $105,745
Dr. Michael Lichter, M.d, M.D
Dermatology — Payments: $87,390
Christopher Mancuso, Do, DO
Dermatology — Payments: $24,400
Mollie Maccormack, M.d, M.D
Dermatology — Payments: $6,465
Rana Abdat, Md, MD
Dermatology — Payments: $782.81
Abdulaziz Alomran, Md, MD
Dermatology — Payments: $405.48